Download Files:
L-826266
$320 – $2,650
Products Details
Product Description
– L-826266 is a selective and competitive EP3 receptor antagonist. L-826266 can be used for convulsive disorders research[1].
Web ID
– HY-19361
Storage Temperature
– -20°C, 3 years (Powder)
Shipping
– Blue Ice
Applications
– Neuroscience-Neuromodulation
Molecular Formula
– C27H21BrClNO4S
References
– [1]M S Oliveira, et al. Modulation of pentylenetetrazol-induced seizures by prostaglandin E2 receptors. Neuroscience. 2008 Apr 9;152(4):1110-8.|[2]Mauro Schneider Oliveira, et al. Prostaglandin E2 modulates Na+,K+-ATPase activity in rat hippocampus: implications for neurological diseases. J Neurochem. 2009 Apr;109(2):416-26.
CAS Number
– 244101-03-9
Molecular Weight
– 570.88
Compound Purity
– 98.03
SMILES
– O=C(NS(=O)(C1=CC(Br)=CC=C1OC)=O)/C=C/C2=CC(Cl)=CC=C2CC3=CC=C4C=CC=CC4=C3
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– DMSO : 10 mg/mL (ultrasonic;warming;heat to 60°C)
Target
– Prostaglandin Receptor
Isoform
– EP
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
